Literature DB >> 10880771

Loss of heterozygosity and microsatellite instability in ductal carcinoma in situ of the breast.

Y Ando1, H Iwase, S Ichihara, S Toyoshima, T Nakamura, H Yamashita, T Toyama, Y Omoto, S Karamatsu, S Mitsuyama, Y Fujii, S Kobayashi.   

Abstract

To investigate the alterations of genetic instabilities in carcinogenesis of the breast, we analyzed the allelotypic profile of 65 ductal carcinomas in situ (DCIS), compared with that of 207 invasive ductal carcinomas (IDC) of the breast. These studies were performed by means of examining microsatellite-length polymorphisms at seven loci (AluVpa, ESR, D11S988, D13S267, D16S398, D17S1159, and D17S855) from microdissected paraffin sections. Allelic loss or imbalance, considered a loss of heterozygosity (LOH), tended to be more frequently seen in IDC than in DCIS. In particular, the frequency of LOH at the 17p locus was significantly higher in IDC than in DCIS (42 vs. 23%, P=0.022). LOH in DCIS was most frequently seen at D16S398 (26%). LOH frequency at D16S398 in low- and intermediate-grade DCIS was higher than that in high-grade DCIS, while LOH frequencies at D11S988 and D17S1159 in low- and intermediate-grade DCIS was lower than those in high-grade DCIS. LOH frequency at D11S988 in non-comedo type DCIS was lower than that in comedo type DCIS. Furthermore, the frequency of microsatellite instability (MSI) at only one locus in DCIS (28%) was statistically higher than that in IDC (6%) (P<0.001), while there was no difference between the frequency of MSI at multiple loci in DCIS (6%) and that in IDC (3%). Together, these observations indicate that chromosomal losses of 16q may occur in low- and intermediate-grade DCIS and those of 11p and 17p may occur high-grade DCIS, and that MSI occurring at only one locus is not yet clear and MSI at multiple loci is uncommon in not only IDC but also DCIS of the breast.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880771     DOI: 10.1016/s0304-3835(00)00467-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  Loss of heterozygosity of the BRCA1 and FHIT genes in patients with sporadic breast cancer from Southern Brazil.

Authors:  S C L Santos; L R Cavalli; I J Cavalli; R S Lima; B R Haddad; E M S F Ribeiro
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

2.  Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.

Authors:  L W M Loo; C Ton; Y-W Wang; D I Grove; H Bouzek; N Vartanian; M-G Lin; X Yuan; T L Lawton; J R Daling; K E Malone; C I Li; L Hsu; P L Porter
Journal:  Genes Chromosomes Cancer       Date:  2008-12       Impact factor: 5.006

3.  Analysis of genome instability in breast cancer.

Authors:  Eldamária de Vargas Wolfgramm; Lyvia Neves Rebello Alves; Elaine Stur; Thaís Tristão Tovar; Mariana Penha De Nadai Sartori; Allan Kardec de Castro Neto; Iúri Drumond Louro
Journal:  Mol Biol Rep       Date:  2012-11-27       Impact factor: 2.316

4.  Validation of transgenic models of breast cancer: ductal carcinoma in situ (DCIS) and Brca1-mutation-related breast cancer.

Authors:  M S Frech; L P Jones; P A Furth
Journal:  Breast Cancer Online       Date:  2005-08-01

5.  ABCC9 Is Downregulated and Prone to Microsatellite Instability on ABCC9tetra in Canine Breast Cancer.

Authors:  Pan Hao; Kai-Yue Song; Si-Qi Wang; Xiao-Jun Huang; Da-Wei Yao; De-Ji Yang
Journal:  Front Vet Sci       Date:  2022-01-07

6.  Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer.

Authors:  Kazuharu Kai; Zhenhuan Zhang; Hiroko Yamashita; Yutaka Yamamoto; Yutaka Miura; Hirotaka Iwase
Journal:  BMC Cancer       Date:  2008-09-16       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.